Quality assessment of meta-analyses evaluating randomized clinical trials to improve the prognosis of septic shock: an overview of systematic reviews

References

• León Gil C, García-Castrillo Riesgo L, Moya Mir M, et al. Consensus document (SEMES-SEMICYUC). Recommendations for the initial and multidisciplinary diagnostic management of severe sepsis in the hospital Emergency Departments. Med Intensiva. 2007;31(7):375–387.
   PubMedGoogle Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775–787.
   PubMed Web of Science ®Google Scholar
• Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–774.
   PubMed Web of Science ®Google Scholar
• Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305–310.
   PubMed Web of Science ®Google Scholar
• Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896–1900.
   PubMed Web of Science ®Google Scholar
• Pussegoda K, Turner L, Garritty C, et al. Systematic review adherence to methodological or reporting quality. Syst Rev. 2017;6(1):131.
   PubMedGoogle Scholar
• Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol. 1991;44(11):1271–1278.
   PubMed Web of Science ®Google Scholar
• Whiting P, Savović J, Higgins JP, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–234.
   PubMed Web of Science ®Google Scholar
• Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7(1):10.
   PubMed Web of Science ®Google Scholar
• Kung J, Chiappelli F, Cajulis OO, et al. From systematic reviews to clinical recommendations for evidence-based health care: validation of Revised Assessment of Multiple Systematic Reviews (RAMSTAR) for grading of clinical relevance. Open Dent J. 2010;4(1):84–91.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Delaney A, Bagshaw SM, Ferland A, et al. A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care. 2005;9(5):R575–R582.
   PubMed Web of Science ®Google Scholar
• Polen MR, Whitlock EP, Wisdom JP, et al. Screening in primary care settings for illicit drug use: staged systematic review for the U.S. preventive services task force. Evidence Synthesis No. 58, Part 1. AHRQ Publication No. 08-05108-EF-s. Rockville (MD): Agency for Healthcare Research and Quality, January; 2008. (Prepared by the Oregon Evidence-based Practice Center under Contract No. 290-02-0024).
   Google Scholar
• Furlan AD, Clarke J, Esmail R, et al. A critical review of reviews on the treatment of chronic low back pain. Spine. 2001;26(7):E155–E162.
   PubMedGoogle Scholar
• Dupuis C, Sonneville R, Adrie C, et al. Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis. Ann Intensive Care. 2017;7(1):5.
   PubMedGoogle Scholar
• Barochia AV, Cui X, Vitberg D, et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med. 2010; 38:668–678.
   PubMed Web of Science ®Google Scholar
• D’Aragon F, Belley-Cote EP, Meade MO, et al. Canadian Critical Care Trials Group. Blood pressure targets for vasopressor therapy: a systematic review. Shock. 2015;43(6):530–539.
   PubMed Web of Science ®Google Scholar
• Wiedermann CJ. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med. 2008;8(1):1.
   PubMedGoogle Scholar
• Dumagay JA, Dagang DJ. Ephinephrine versus stadard treatment (norepinephrine/dopamine) as vasopressor therapy in adults with septic shock: a meta-analysis. Acta Med Philipp. 2011;45:61–68.
   Google Scholar
• Rowan KM, Angus DC, Bailey M, et al. Early, goal-directed therapy for septic shock - a patient-level meta-analysis. N Engl J Med. 2017;376(23):2223–2234.
   PubMed Web of Science ®Google Scholar
• Boyer A, Chadda K, Salah A, et al. Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality. Int J Clin Pharmacol Therap. 2006;44(07):309–318.
   PubMedGoogle Scholar
• Holst LB. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit. Dan Med J. 2016;63:B5209.
   PubMed Web of Science ®Google Scholar
• Katsios C, Doumouras A, Shaefi S, et al. Conservative fluid strategies decrease mortality in sepsis: a systematic review and meta-analysis. Crit Care Med. 2016;4:92.
   Google Scholar
• Uchiyama N, Nishimura N, Jinta T, et al. Efficacy of corticosteroids on survival in patients with sepsis and septic shock: meta-analysis. Crit Care. 2009; 13(1):P324.
   Google Scholar
• Qiu P, Cui X, Sun J, et al. Selective tumor necrosis factor inhibitors’ effect on survival in septic shock: a meta-analysis. Am J Respir Crit Care Med. 2012;185:A6002.
   Google Scholar
• Zhang Z. Antipyretic therapy in critically ill patients with established sepsis: a trial sequential analysis. PLoS One. 2015;10(2):e0117279.
   PubMed Web of Science ®Google Scholar
• Pontes-Arruda A, Martins LF, de Lima SM, et al. Investigating Nutritional Therapy with EPA, GLA and Antioxidants Role in Sepsis Treatment (INTERSEPT) Study Group. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit Care. 2011;15(3):R144.
   PubMed Web of Science ®Google Scholar
• Paul M, Shani V, Muchtar E, et al. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54(11):4851–4863.
   PubMed Web of Science ®Google Scholar
• Tigabu BM, Davari M, Kebriaeezadeh A, et al. Fluid volume, fluid balance and patient outcome in severe sepsis and septic shock: a systematic review. J Crit Care. 2018;48:153–159.
   PubMed Web of Science ®Google Scholar
• Williamson DR, Lapointe M. The hypothalamic-pituitary-adrenal axis and low-dose glucocorticoids in the treatment of septic shock. Pharmacotherapy. 2003;23(4):514–525.
   PubMed Web of Science ®Google Scholar
• Ho KM, Tan JA. Use of L’Abbé and pooled calibration plots to assess the relationship between severity of illness and effectiveness in studies of corticosteroids for severe sepsis. Br J Anaesth. 2011;106(4):528–536.
   PubMed Web of Science ®Google Scholar
• Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care. 2013;17(3):R96.
   PubMed Web of Science ®Google Scholar
• Soares MO, Welton NJ, Harrison DA, et al. Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial. Crit Care. 2014;18(6):649.
   PubMed Web of Science ®Google Scholar
• Mou Z, Lv Z, Li Y, et al. Clinical effect of Shenfu injection in patients with septic shock: a meta-analysis and systematic review. Evid Based Complement Alternat Med. 2015;2015:1–10.
   Web of Science ®Google Scholar
• Moran JL, Graham PL, Rockliff S, et al. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care. 2010;14(4):R134.
   PubMed Web of Science ®Google Scholar
• Bansal M, Farrugia A, Balboni S, et al. Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies. Curr Drug Safety. 2013;8(4):236–245.
   PubMedGoogle Scholar
• Minneci PC, Deans KJ, Banks SM, et al. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med. 2004;141(1):47–56.
   PubMed Web of Science ®Google Scholar
• Yamakawa K, Murao S, Aihara M. Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis. Thromb Haemost. 2019;119(01):056–065.
   PubMedGoogle Scholar
• Lu C, Sharma S, McIntyre L, et al. Omega-3 supplementation in patients with sepsis: a systematic review and meta-analysis of randomized trials. Ann Intensive Care. 2017;7:58.
   PubMed Web of Science ®Google Scholar
• Fang F, Zhang Y, Tang J, et al. Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(2):213–223.
   PubMed Web of Science ®Google Scholar
• Li D, Li X, Cui W, et al. Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock. Cochrane Database Syst Rev. 2018;12:CD010593.
   PubMedGoogle Scholar
• Zou Y, Ma K, Xiong JB, et al. Comparison of the effects of albumin and crystalloid on mortality among patients with septic shock: systematic review with meta-analysis and trial sequential analysis. Sao Paulo Med J. 2018;136(5):421–432.
   PubMed Web of Science ®Google Scholar
• Kuriyama A, Katsura M, Urushidani S, et al. Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials. Ann Transl Med. 2018;6(11):206–206.
   PubMed Web of Science ®Google Scholar
• Fujii T, Ganeko R, Kataoka Y, et al. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018;44(2):167–178.
   PubMed Web of Science ®Google Scholar
• Wang B, Chen R, Guo X, et al. Effects of levosimendan on mortality in patients with septic shock: systematic review with meta-analysis and trial sequential analysis. Oncotarget. 2017;8(59):100524–100532.
   PubMedGoogle Scholar
• Sjövall F, Perner A, Hylander Møller M. Empirical mono- versus combination antibiotic therapy in adult intensive care patients with severe sepsis – A systematic review with meta-analysis and trial sequential analysis. J Infect. 2017;74(4):331–344.
   PubMed Web of Science ®Google Scholar
• Xu JY, Chen QH, Liu SQ, et al. The effect of early goal-directed therapy on outcome in adult severe sepsis and septic shock patients: a meta-analysis of randomized clinical trials. Anesth Analg. 2016;123(2):371–381.
   PubMed Web of Science ®Google Scholar
• Angus DC, Barnato AE, Bell D, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe investigators. Intensive Care Med. 2015;41(9):1549–1560.
   PubMed Web of Science ®Google Scholar
• Rusconi AM, Bossi I, Lampard JG, et al. Early goal-directed therapy vs usual care in the treatment of severe sepsis and septic shock: a systematic review and meta-analysis. Intern Emerg Med. 2015;10(6):731–743.
   PubMed Web of Science ®Google Scholar
• Chelkeba L, Ahmadi A, Abdollahi M, et al. Early goal-directed therapy reduces mortality in adult patients with severe sepsis and septic shock: systematic review and meta-analysis. Indian J Crit Care Med. 2015;19(7):401–411.
   PubMed Web of Science ®Google Scholar
• Volbeda M, Wetterslev J, Gluud C, et al. Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2015;41(7):1220–1234.
   PubMed Web of Science ®Google Scholar
• Zarychanski R, Abou-Setta AM, Kanji S, et al. Canadian Critical Care Trials Group. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015;43(3):511–518.
   PubMed Web of Science ®Google Scholar
• Jiang L, Jiang S, Zhang M, et al. Albumin versus other fluids for fluid resuscitation in patients with sepsis: a meta-analysis. PLoS One. 2014;9(12):e114666.
   PubMed Web of Science ®Google Scholar
• Lv S, Han M, Yi R, et al. Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis. Int J Clin Pract. 2014;68(4):520–528.
   PubMed Web of Science ®Google Scholar
• Patel A, Laffan MA, Waheed U, et al. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349(10):g4561.
   PubMedGoogle Scholar
• Xu JY, Chen QH, Xie JF, et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care. 2014;18(6):702.
   PubMed Web of Science ®Google Scholar
• Zhou F, Peng Z, Murugan R, et al. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013;41(9):2209–2220.
   PubMed Web of Science ®Google Scholar
• Prkno A, Wacker C, Brunkhorst FM, et al. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock–a systematic review and meta-analysis. Crit Care. 2013;17(6):R291.
   PubMed Web of Science ®Google Scholar
• Lai PS, Matteau A, Iddriss A, et al. An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock. Minerva Anestesiol. 2013;79:33–43.
   PubMed Web of Science ®Google Scholar
• Martí-Carvajal AJ, Solà I, Lathyris D, et al. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients. Cochrane Database Syst Rev. 2012;12:CD004388.
   PubMedGoogle Scholar
• Latour-Pérez J, Palencia-Herrejón E, Gómez-Tello V, et al. Intensity of continuous renal replacement therapies in patients with severe sepsis and septic shock: a systematic review and meta-analysis. Anaesth Intensive Care. 2011;39(3):373–383.
   PubMed Web of Science ®Google Scholar
• Vasu TS, Cavallazzi R, Hirani A, et al. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. J Intensive Care Med. 2012;27(3):172–178.
   PubMedGoogle Scholar
• Sligl WI, Milner DA, Jr, Sundar S, et al. Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis. 2009;49(1):93–101.
   PubMed Web of Science ®Google Scholar
• Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA. 2009;301(22):2362–2375.
   PubMed Web of Science ®Google Scholar
• Minneci PC, Deans KJ, Eichacker PQ, et al. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect. 2009;15(4):308–318.
   PubMed Web of Science ®Google Scholar
• Jones AE, Brown MD, Trzeciak S, et al. Emergency Medicine Shock Research Network investigators. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med. 2008;36:2734–2739.
   PubMed Web of Science ®Google Scholar
• Kreymann KG, de Heer G, Nierhaus A, et al. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med. 2007;35:2677–2685.
   PubMed Web of Science ®Google Scholar
• Cruz DN, Perazella MA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007;11(2):R47.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med. 2007;35:2686–2692.
   PubMed Web of Science ®Google Scholar
• Turgeon AF, Hutton B, Fergusson DA, et al. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med. 2007;146(3):193–203.
   PubMed Web of Science ®Google Scholar
• Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004;329(7464):480.
   PubMedGoogle Scholar
• Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995;23(8):1430–1439.
   PubMed Web of Science ®Google Scholar
• Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med. 1995;23(7):1294–1303.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, et al. Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(2):d5928.
   PubMed Web of Science ®Google Scholar